Vivatmo proTM EU-study: FeNO Monitoring in Asthmatic Patients Responding to ICS Treatment

NCT05553379 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2022-09-23

No results posted yet for this study

Summary

This is a multi-center study to evaluate fractional exhaled nitric oxide (FeNO) measured with the Vivatmo pro in adult and pediatric subjects.

Conditions

Interventions

DIAGNOSTIC_TEST

FeNO measurement

FeNO measurement at each visit

Sponsors & Collaborators

  • Bosch Healthcare Solutions GmbH

    lead INDUSTRY

Eligibility

Min Age
7 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-15
Primary Completion
2022-09-15
Completion
2022-10-15
FDA Device
Yes

Countries

  • Czechia
  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05553379 on ClinicalTrials.gov